AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
55,000
Frequently Asked Questions
What is Market Cap of Abbvie Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Abbvie Inc market cap is $409.03B.
What is the 52-week high for Abbvie Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Abbvie Inc 52 week high is $232.35 as of October 02, 2025.
What is the 52-week low for Abbvie Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Abbvie Inc 52 week low is $163.81 as of October 02, 2025.
What is Abbvie Inc stock price today?
Abbvie Inc stock price today is $244.38.
What was Abbvie Inc stock price yesterday?
Abbvie Inc stock price yesterday was $231.54.
What is the PE ratio of Abbvie Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Abbvie Inc’s P/E ratio is 110.19.
What is the Price-to-Book ratio of Abbvie Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Abbvie Inc P/B ratio is -2234.9421.
What is the 50-day moving average of Abbvie Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Abbvie Inc 50-day moving average is $207.47.